thelancet.com/journals/lance ACHIEVE 2: in metformintreated T2D, oncedaily oral #orforglipron lowered HbA1c more than #dapagliflozin (up to ~1.6% vs ~0.8% at 40 weeks) and produced greater weight loss (~57% vs ~23%), with the expected GLP1 GI tolerability profile but low hypoglycemia and similar serious events
This medicine is used to relieve pain of non-serious arthritic conditions, rheumatic and muscular pain, backache, neuralgia (nerve pain), headache, migraine, dental pain, period pain, fever (high temperature) and the symptoms of colds and flu
The trial was sponsored by the drug manufacturer Novo Nordisk and published in the New England Journal of Medicine
PlexusDx practitioners review your full medication list before starting treatment to identify potential interactions and adjust strategy accordingly
Of course
When to Reassess Your Diet as Your Dose Increases Tirzepatide dosing typically starts low and increases gradually over several weeks or months to find your optimal therapeutic level